These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. 11C-PiB and 124I-Antibody PET Provide Differing Estimates of Brain Amyloid-β After Therapeutic Intervention. Meier SR, Sehlin D, Roshanbin S, Falk VL, Saito T, Saido TC, Neumann U, Rokka J, Eriksson J, Syvänen S. J Nucl Med; 2022 Feb; 63(2):302-309. PubMed ID: 34088777 [Abstract] [Full Text] [Related]
23. PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease. Toyama H, Ye D, Ichise M, Liow JS, Cai L, Jacobowitz D, Musachio JL, Hong J, Crescenzo M, Tipre D, Lu JQ, Zoghbi S, Vines DC, Seidel J, Katada K, Green MV, Pike VW, Cohen RM, Innis RB. Eur J Nucl Med Mol Imaging; 2005 May; 32(5):593-600. PubMed ID: 15791432 [Abstract] [Full Text] [Related]
24. Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain. Okamura N, Suemoto T, Shimadzu H, Suzuki M, Shiomitsu T, Akatsu H, Yamamoto T, Staufenbiel M, Yanai K, Arai H, Sasaki H, Kudo Y, Sawada T. J Neurosci; 2004 Mar 10; 24(10):2535-41. PubMed ID: 15014129 [Abstract] [Full Text] [Related]
28. Preclinical and clinical study on [18F]DRKXH1: a novel β-amyloid PET tracer for Alzheimer's disease. Xu M, Guo J, Gu J, Zhang L, Liu Z, Ding L, Fu H, Ma Y, Liang S, Wang H. Eur J Nucl Med Mol Imaging; 2022 Jan 10; 49(2):652-663. PubMed ID: 34292345 [Abstract] [Full Text] [Related]
30. Characterization and first human investigation of FIBT, a novel fluorinated Aβ plaque neuroimaging PET radioligand. Yousefi BH, Manook A, Grimmer T, Arzberger T, von Reutern B, Henriksen G, Drzezga A, Förster S, Schwaiger M, Wester HJ. ACS Chem Neurosci; 2015 Mar 18; 6(3):428-37. PubMed ID: 25482310 [Abstract] [Full Text] [Related]
31. Preclinical characterization of a novel class of 18F-labeled PET tracers for amyloid-β. Brockschnieder D, Schmitt-Willich H, Heinrich T, Varrone A, Gulyás B, Toth M, Andersson J, Boemer U, Krause S, Friebe M, Dinkelborg L, Halldin C, Dyrks T. J Nucl Med; 2012 Nov 18; 53(11):1794-801. PubMed ID: 23008501 [Abstract] [Full Text] [Related]
32. AZD2184: a radioligand for sensitive detection of beta-amyloid deposits. Johnson AE, Jeppsson F, Sandell J, Wensbo D, Neelissen JA, Juréus A, Ström P, Norman H, Farde L, Svensson SP. J Neurochem; 2009 Mar 18; 108(5):1177-86. PubMed ID: 19141073 [Abstract] [Full Text] [Related]
33. High detection sensitivity with antibody-based PET radioligand for amyloid beta in brain. Fang XT, Hultqvist G, Meier SR, Antoni G, Sehlin D, Syvänen S. Neuroimage; 2019 Jan 01; 184():881-888. PubMed ID: 30300753 [Abstract] [Full Text] [Related]
36. Synthesis and evaluation of 11C-labeled imidazo[2,1-b]benzothiazoles (IBTs) as PET tracers for imaging β-amyloid plaques in Alzheimer's disease. Yousefi BH, Manook A, Drzezga A, von Reutern B, Schwaiger M, Wester HJ, Henriksen G. J Med Chem; 2011 Feb 24; 54(4):949-56. PubMed ID: 21275403 [Abstract] [Full Text] [Related]
38. Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients. Kung MP, Skovronsky DM, Hou C, Zhuang ZP, Gur TL, Zhang B, Trojanowski JQ, Lee VM, Kung HF. J Mol Neurosci; 2003 Feb 24; 20(1):15-24. PubMed ID: 12663930 [Abstract] [Full Text] [Related]
39. Generation of Clickable Pittsburgh Compound B for the Detection and Capture of β-Amyloid in Alzheimer's Disease Brain. Diner I, Dooyema J, Gearing M, Walker LC, Seyfried NT. Bioconjug Chem; 2017 Oct 18; 28(10):2627-2637. PubMed ID: 28862836 [Abstract] [Full Text] [Related]
40. Labeling of cerebral amyloid beta deposits in vivo using intranasal basic fibroblast growth factor and serum amyloid P component in mice. Shi J, Perry G, Berridge MS, Aliev G, Siedlak SL, Smith MA, LaManna JC, Friedland RP. J Nucl Med; 2002 Aug 18; 43(8):1044-51. PubMed ID: 12163630 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]